We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Microplastics Versus Microbiome: The Infantile Gut’s Battle for Health
Summary
This review examines how microplastics and nanoplastics disrupt the developing gut microbiome in infants, covering potential effects on microbial stabilization, antibiotic resistance gene transfer through biofilm formation, and implications for long-term metabolic and immune health.
Gut microbiota play a critical role in long-term health by supporting metabolism, immune function, inflammation regulation, and neurological development via the gut–brain axis. Beneficial bacteria enhance gut integrity through short-chain fatty acid production, pathogen inhibition, and mucosal barrier support. However, microplastics (MPs) and nanoplastics (NPs) can disrupt microbiome development, particularly in infants. MPs may delay microbial stabilization and promote antibiotic resistance through biofilm-associated gene transfer. In neonates, especially those exposed to intensive care, antibiotics, or formula feeding, MPs/NPs present an added challenge to microbiome establishment. Probiotics offer a potential intervention by restoring microbial balance, strengthening gut barriers, and mitigating inflammation. Certain strains can bind or degrade environmental toxins, including MPs, heavy metals, and endocrine disruptors. Clinical studies support the use of probiotic mixtures to restore eubiosis. Given the limited availability of safe plastic alternatives in neonatal care, enhancing the gut microbiome through probiotics may help counteract the adverse effects of MPs/NPs. However, due to safety concerns—such as the FDA’s warning against live probiotics in preterm infants—future research should explore innovative, safe bioremediation strategies to support gut health in this vulnerable population.
Sign in to start a discussion.
More Papers Like This
Uncovering the nexus of human health hazards of nanoplastics, gut-dysbiosis and antibiotic-resistance
This review provides the first comprehensive synthesis specifically linking nanoplastic exposure to gut dysbiosis and antibiotic resistance gene propagation, finding that nanoplastics suppress beneficial microbes while fostering pathogens and creating conditions that promote horizontal transfer of resistance genes.
The ant that may well destroy a whole dam: a systematic review of the health implication of nanoplastics/microplastics through gut microbiota
This systematic review summarizes existing research on how nanoplastics and microplastics disrupt gut bacteria in various organisms. The findings show that plastic particle exposure consistently alters gut microbiome composition, which in turn affects the host's immune function, metabolism, and overall health. These gut bacteria changes may be a key pathway through which microplastics harm human health.
[Effect of microand nanoplastics on the gastrointestinal mucosa and intestinal microbiome].
This review examines how micro- and nanoplastics entering through the food chain affect the gastrointestinal tract, finding evidence of disruption to gut mucosal integrity and intestinal microbiome composition, with implications for digestive health and systemic immune function.
Exploring Bacterial Interactions with Microplastics in the Human Gut Microbiome
This review explored how microplastics interact with bacteria in the human gut microbiome, examining evidence that plastic particles can alter microbial community composition, enable colonization by pathogens, and facilitate horizontal gene transfer of antibiotic resistance genes. The gut microbiome appears to be a significant site of microplastic-microorganism interaction.
Effects of Microplastics on the Intestinal Barrier, Gut Microbiota and Antibiotic Resistance Genes: A Mini-Review
This review examines how microplastics affect the intestinal barrier, gut microbiota, and antibiotic resistance gene profiles. Researchers found that while microplastics reduced the bioaccumulation of certain antibiotics like tetracycline and sulfamethoxazole, they enhanced the effects on gut microbial communities and the antibiotic resistome, suggesting potential risks from combined microplastic and antibiotic exposure.